Literature DB >> 11534976

Estradiol induces formation of dendritic spines in hippocampal neurons: functional correlates.

M Segal1, D Murphy.   

Abstract

Dissociated cultured rat hippocampal pyramidal neurons respond to estradiol with a time-dependent, twofold increase in density of their dendritic spines. This effect is mediated by an estrogen receptor, probably of the alpha nuclear receptor type. In searching for the molecular mechanisms leading from the initial activation of the estrogen receptor to the final formation of new dendritic spines, we found that estradiol acts on GABAergic interneurons expressing the estrogen receptor by decreasing their inhibitory tone. In culture, this is assumed to cause a shift in the balance between excitation and inhibition toward enhanced excitation, overactivation of the pyramidal neurons, and subsequent formation of novel dendritic spines. The action of estradiol on spine formation is mediated by phosphorylation of cyclic AMP response element binding protein in the pyramidal neurons and is blocked when inhibition is enhanced by diazepam and when excitation is blocked by tetrodotoxin. Progesterone blocks the effect of estradiol on dendritic spines through its conversion to tetrahydroprogesterone, which enhances GABAergic inhibition. Subsequent to formation of novel dendritic spines, there is an increase in the density of glutamatergic receptors in the affected cells, an increase in the cellular calcium response to glutamate, and an increase in network synaptic activity among the cultured neurons. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534976     DOI: 10.1006/hbeh.2001.1688

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  19 in total

Review 1.  Mechanisms of dendritic maturation.

Authors:  Frederic Libersat; Carsten Duch
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 2.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

3.  Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortex.

Authors:  Elinor Blumkin; Tamar Levav-Rabkin; Osnat Melamed; Dalia Galron; Hava M Golan
Journal:  Neuropsychopharmacology       Date:  2011-04-13       Impact factor: 7.853

4.  Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice.

Authors:  Amanda M Dossat; Katherine N Wright; Caroline E Strong; Mohamed Kabbaj
Journal:  Neuropharmacology       Date:  2017-11-21       Impact factor: 5.250

Review 5.  Molecular mechanisms underlying the memory-enhancing effects of estradiol.

Authors:  Karyn M Frick
Journal:  Horm Behav       Date:  2015-05-08       Impact factor: 3.587

6.  The role of cAMP response element-binding protein in estrogen negative feedback control of gonadotropin-releasing hormone neurons.

Authors:  Andrea Kwakowsky; Allan E Herbison; István M Ábrahám
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

Review 7.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

8.  Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brain-derived neurotrophic factor.

Authors:  Helen E Scharfman; Thomas C Mercurio; Jeffrey H Goodman; Marlene A Wilson; Neil J MacLusky
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

9.  Estrous cycle phase and gonadal hormones influence conditioned fear extinction.

Authors:  M R Milad; S A Igoe; K Lebron-Milad; J E Novales
Journal:  Neuroscience       Date:  2009-09-15       Impact factor: 3.590

10.  Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.

Authors:  Sarah J Bertrand; Charles F Mactutus; Marina V Aksenova; Tori D Espensen-Sturges; Rosemarie M Booze
Journal:  J Neurochem       Date:  2013-08-26       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.